Beryl Drugs Key Metrics

BSE: 524606 | NSE: - | ISIN: INE415H01017 | Sector: Biotechnology & Drugs

33.10 +0.57 (1.75%)Updated : 26 Nov 2024

Ratios

Return on average equity - 5 year average	2.97
Net Income/employee - trailing 12 month	-
Revenue/employee - most recent fiscal year	-
Return on investment - most recent fiscal year	6.71
Return on average assets - most recent fiscal year	4.39
Receivables turnover - most recent fiscal year	3.69
Return on investment - trailing 12 month	-
Return on average assets - trailing 12 month	-
Inventory turnover - most recent fiscal year	11.36
Inventory turnover - trailing 12 month	-
Revenue/employee - trailing 12 month	-
Return on average assets - 5 year average	1.34
Net Income/employee - most recent fiscal year	-
Return on average equity - trailing 12 month	-
Receivables turnover - trailing 12 month	-
Asset turnover - most recent fiscal year	1.53
Asset turnover - trailing 12 month	-
Return on average equity - most recent fiscal year	9.05
Return on investment - 5 year average	2.25